PRAX Praxis Precision Medicines, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Praxis Precision Medicines (PRAX) Stock: Buy, Sell, or Hold?

$346.21
+8.62 (+2.55%) β–²
5d: +21.57% 30d: +42.27% 90d: -6.04%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (27%)
Quality Score
38/100
Position
EXTENDED
30-Day Fair Range
$247.52 – $300.57
Position: EXTENDED
Forward P/E & Valuation
-35.7x
Next 12M consensus est.
Wall Street Target
$676.20
+95.3% upside
Options IV & Volume
33th pct IV
HIGH volume confirmation
Support / Resistance
$260.77 / $351.64
Trend: Downtrend
πŸ’‘Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR BETTER ENTRY: PRAX is 15.2% above its trading range ($300.57). While momentum could continue, risk/reward favors waiting for a pullback.

Get Alerted When PRAX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: PRAX is currently trading at $346.21, which is considered extended relative to its 30-day fair value range of $247.52 to $300.57.

Technical Outlook: Technically, PRAX is in a downtrend. The price is approaching resistance at $351.64. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: PRAX scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $676.20 (+95.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position EXTENDED
Historical Trading Range $247.52 - $300.57
Company Quality Score 38/100 (SELL)
Options IV Signal 33th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 27.1%

Trading Range & Key Levels

30-Day Trading Range $247.52 - $300.57
Current vs Trading Range EXTENDED
Expected Move (7 Days) Β±$44.40 (12.8%)
Support Level $260.77
Resistance Level $351.64
Current Trend Downtrend
Technical data as of Nov 11, 2026

Protect Your Profits

Holding PRAX? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • BEARISH: Price significantly overextended (+15.2% above its trading range)
  • NEUTRAL: Options fairly priced (IV 33th percentile)
  • BEARISH: Weak technical setup (15/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 95.3% below Wall St target ($676.20)
  • WARNING: Composite score 38/100 in the bottom quintile β€” this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -35.70
Wall Street Target $676.20 (+95.3%)
Revenue Growth (YoY) 1349.1%
Share PRAX Analysis

Share this live PRAX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (PRAX)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary: Bullish sentiment on StockTwits as HC Wainwright reiterated a Buy rating and $1201 price target for $PRAX. Praxis Precision Medicines' P/B ratio is higher than the industry average and peer group, indicating investors are paying a premium for the biotech stock.
Key Retail Themes: Buy rating and price target from HC Wainwright Praxis Precision Medicines' P/B ratio vs industry and peer groups
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:17 AM ET
Data refreshes hourly during market hours. Next update: 2:17 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for PRAX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
RVMD
Revolution Medicines Inc
STRONG BUY
25 analysts
$261 53 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
21 analysts
$95 41 HOLD
JANX
Janux Therapeutics Inc
STRONG BUY
18 analysts
$32 51 HOLD
SNDX
Syndax Pharmaceuticals I…
STRONG BUY
12 analysts
$35 60 HOLD
ACHV
Achieve Life Sciences Inc
STRONG BUY
12 analysts
$14 56 HOLD

Advanced PRAX Option Strategies

Professional options setups generated by AI based on today's PRAX price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive PRAX Research Pages
PRAX Technical Chart PRAX Price Prediction PRAX Intrinsic Value DCF PRAX Earnings Date Why is PRAX Moving Today? PRAX Investment Advisor PRAX Fair Price Analyzer PRAX Options Chain PRAX Options Advisor PRAX Options Analysis PRAX Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals